A new report published in the New England Journal of Medicine on Wednesday suggests that Pfizer-BioNTech’s Covid-19 vaccine can protect people against concerning new coronavirus variants ...

Pfizer and its partner BioNTech said that while two doses may not be strong enough to prevent infection, lab tests showed a booster increased by 25-fold people's levels of antibodies capable of ...

Pfizer and its partner BioNTech said that while two doses may not be strong enough to prevent infection, lab tests showed a booster increased by 25-fold people's levels of antibodies capable of ...

Pfizer said it will still work toward a specially tailored shot and could have it available by March “in the event that an adaption is needed to further increase the level and duration of ...

Zai Lab holds an exclusive licence from Entasis Therapeutics for developing and commercialising XACDURO across a wide range of Asian territories, including Korea, Greater China, Vietnam and other ...

A new report published in the New England Journal of Medicine on Wednesday suggests that Pfizer-BioNTech's Covid-19 vaccine can protect people against concerning new coronavirus variants.

Pfizer and its partner BioNTech said that while two doses may not be strong enough to prevent infection, lab tests showed a booster increased by 25-fold people's levels of antibodies capable of ...

For the study, researchers at Pfizer and the University of Texas Medical Branch genetically engineered versions of the virus to carry some of the mutations found in B.1.351.

Pfizer and its partner BioNTech said that while two doses may not be strong enough to prevent infection, lab tests showed a booster increased by 25-fold people's levels of antibodies capable of ...

Pfizer and its partner BioNTech said that while two doses may not be strong enough to prevent infection, lab tests showed a booster increased by 25-fold people's levels of antibodies capable of ...

Pfizer and its partner BioNTech said that while two doses may not be strong enough to prevent infection, lab tests showed a booster increased by 25-fold people's levels of antibodies capable of ...